RhumbLine Advisers
CGEM icon

RhumbLine Advisers’s Cullinan Oncology CGEM Stock Holding History

RhumbLine Advisers’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$959K Buy
67,516
+276
+0.4% +$3.55K ﹤0.01% 2213
2025
Q4 		$696K Sell
67,240
-4,569
-6% -$41.2K ﹤0.01% 2439
2025
Q3 		$426K Sell
71,809
-2,296
-3% -$16.8K ﹤0.01% 2801
2025
Q2 		$558K Buy
74,105
+2,767
+4% +$22.2K ﹤0.01% 2619
2025
Q1 		$540K Buy
71,338
+3,130
+5% +$30K ﹤0.01% 2530
2024
Q4 		$831K Buy
68,208
+5,348
+9% +$76.9K ﹤0.01% 2336
2024
Q3 		$1.05M Buy
62,860
+8,509
+16% +$151K ﹤0.01% 2243
2024
Q2 		$948K Buy
54,351
+7,649
+16% +$163K ﹤0.01% 2278
2024
Q1 		$796K Buy
46,702
+972
+2% +$15K ﹤0.01% 2386
2023
Q4 		$466K Buy
45,730
+491
+1% +$4.35K ﹤0.01% 2699
2023
Q3 		$409K Sell
45,239
-988
-2% -$10.3K ﹤0.01% 2732
2023
Q2 		$497K Sell
46,227
-4,866
-10% -$51.7K ﹤0.01% 2689
2023
Q1 		$523K Buy
51,093
+4,400
+9% +$48.5K ﹤0.01% 2411
2022
Q4 		$493K Buy
46,693
+911
+2% +$11.1K ﹤0.01% 2469
2022
Q3 		$587K Buy
45,782
+2,659
+6% +$35.8K ﹤0.01% 2422
2022
Q2 		$553K Buy
43,123
+11,078
+35% +$126K ﹤0.01% 2451
2022
Q1 		$336K Buy
32,045
+1,445
+5% +$19.5K ﹤0.01% 2600
2021
Q4 		$472K Sell
30,600
-425
-1% -$8.48K ﹤0.01% 2532
2021
Q3 		$700K Buy
31,025
+15,998
+106% +$428K ﹤0.01% 2394
2021
Q2 		$387K Buy
15,027
+3,443
+30% +$106K ﹤0.01% 2675
2021
Q1 		$483K Buy
+11,584
New +$470K ﹤0.01% 2515

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return